| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |